"I have used Science Founders Group for analytical testing, method development, validation and verification for various product types since 2016. They provide professional consulting and guidance to assist you to ensure you meet your testing requirements. They are registered with the FDA for pharmaceutical testing and are cGMP/GLP compliant. Our facility manufactures bulk raw materials and we have customers who sometimes need counsel or guidance in selecting a method for finished good analysis or performance studies that may be above and beyond the USP Monograph, luckily for us we can refer them to Science Founders Group because they have a well rounded team with someone from each department, including Research and Development, a team who are extremely versed in pharmaceutical analysis and requirements and they work with your team to complete your project. I trust them enough to refer this team to our valued customers. They offer guidance and consult when needed and always provide me with additional documentation for audits or customers when needed. I cannot say enough great things about this team. They also have a large capacity of ICH approved, controlled stability chambers and can run full stability studies meeting ICH requirements. As a part of our qualification process we must audit all third party test facilities and they have proven to be compliant and current. This team not only has the capability to develop and establish new methods, run USP Monograph analysis but also to EP standards. Another new aspect we have found is method development and transfer, to get the method fully established by Founders, gather sufficient data and with their assistance transfer the method internally which is extremely helpful if you are waiting on equipment to test internally but need the method developed and validated. This team works with you and becomes an extended part of your team. The pricing is reasonable and comparable to other laboratories we have used in the past but the service and capabilities here are outstanding."